Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 10, 2018
Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule
VANCOUVER , May 10, 2018 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter ...
May 10, 2018
Aptose Reports Results for the First Quarter Ended March 31, 2018
SAN DIEGO and TORONTO, May 10, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (APTO) (APS.TO), a clinical-stage company developing highly differentiated ...
May 10, 2018
Rockwell Medical Reports First Quarter 2018 Results
WIXOM, Mich., May 10, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI), a fully-integrated specialty pharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney ...
May 10, 2018
Pernix Therapeutics Reports First Quarter 2018 Financial Results
MORRISTOWN, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (PTX), a specialty pharmaceutical company, announced today its financial results for the three ...
May 10, 2018
HTG Molecular Diagnostics Reports First Quarter 2018 Results
TUCSON, Ariz., May 10, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a provider of instruments, reagents and services for molecular profiling applications, ...
May 10, 2018
BioDelivery Sciences Reports Positive First Quarter 2018 Financial Results and Provides Corporate Update
RALEIGH, N.C., May 10, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI) today reported financial results for the first quarter ended March 31, 2018 ...
May 10, 2018
Pfenex Reports First Quarter 2018 Results and Provides Business Update
SAN DIEGO, May 10, 2018 /PRNewswire/ -- Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression Technology® ...
May 10, 2018
Neovasc Announces Results for the First Quarter 2018
VANCOUVER , May 10, 2018 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter ...
May 10, 2018
BioLife Solutions Announces First Quarter 2018 Financial Results
BOTHELL, Wash., May 10, 2018 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS) ("BioLife"), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic ...
May 10, 2018
BioTime Reports First Quarter Results and Recent Corporate Accomplishments
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today reported financial results for the first quarter ended March 31, ...
May 10, 2018
Fortress Biotech Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
NEW YORK, May 10, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and ...
May 10, 2018
Checkpoint Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
NEW YORK, May 10, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization ...
May 10, 2018
Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on May 15, 2018
CRANBURY, N.J., May 10, 2018 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its third quarter, fiscal year 2018 operating results on Tuesday, May ...
May 10, 2018
Essa Pharma Inc. Regains Compliance with NASDAQ Listing Requirements
HOUSTON and VANCOUVER , May 10, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, Nasdaq: EPIX), a pre-clinical stage pharmaceutical company ...
May 9, 2018
Lipocine Receives Complete Response Letter for TLANDO From U.S. Food and Drug Administration
SALT LAKE CITY, May 9, 2018 /PRNewswire/ -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, announced today that it has received a Complete Response Letter ("CRL") ...
May 9, 2018
Kamada to Announce First Quarter 2018 Financial Results and Host Conference Call on May 15
REHOVOT, Israel, May 09, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (KMDA) (KMDA.TA), a plasma-derived protein therapeutics company, today announced that it will release financial results ...
May 9, 2018
Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2018 Financial Results
TEL AVIV, Israel, May 9, 2018 /PRNewswire/ --Galmed Pharmaceuticals Ltd. (GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the ...
May 9, 2018
ProQR Announces Results for the First Quarter of 2018
LEIDEN, the Netherlands, May 09, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (PRQR), a company dedicated to changing lives through the creation of transformative RNA ...
May 9, 2018
Paratek Pharmaceuticals Reports First Quarter 2018 Financial Results
BOSTON, May 09, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
May 9, 2018
Palatin Technologies Presents Positive Preclinical MC1 Receptor Agonist Data at TIDES: Oligonucleotide and Peptide Therapeutics 2018 Meeting in Boston, Massachusetts
CRANBURY, N.J., May 9, 2018 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of ...
Page 43 of 117